Compare CUBI & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CUBI | TMDX |
|---|---|---|
| Founded | 1994 | 1998 |
| Country | United States | United States |
| Employees | 869 | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | N/A | 2019 |
| Metric | CUBI | TMDX |
|---|---|---|
| Price | $75.51 | $68.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $85.00 | ★ $148.22 |
| AVG Volume (30 Days) | 303.1K | ★ 1.7M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | $24.95 | $24.25 |
| Revenue Next Year | $9.50 | $18.75 |
| P/E Ratio | ★ $11.78 | $343.30 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $50.06 | $60.11 |
| 52 Week High | $82.56 | $156.00 |
| Indicator | CUBI | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 52.69 | 31.56 |
| Support Level | $72.29 | $60.11 |
| Resistance Level | $79.42 | $142.44 |
| Average True Range (ATR) | 1.96 | 4.65 |
| MACD | -0.17 | 0.48 |
| Stochastic Oscillator | 47.16 | 22.22 |
Customers Bancorp Inc is a bank holding company conducting banking activities through its wholly owned subsidiary, Customers Bank. The Bank provides commercial and consumer customers the stability of a regulated financial institution supported by risk management. It serves commercial and corporate businesses nationwide, including healthcare, real estate, specialty finance, fund finance, technology and venture capital banking, mortgage finance and commercial equipment financing, and provides payments and treasury services. The Bank also serves consumers through its branch network, offering residential mortgages and personal loan and deposit products, including Banking-as-a-Service, with services delivered predominantly in Southeastern and Central Pennsylvania, New York, and other states.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.